Literature DB >> 2542763

Isolation of human sequences that replicate autonomously in human cells.

P J Krysan1, S B Haase, M P Calos.   

Abstract

We have isolated a heterogeneous collection of human genomic sequences which replicate autonomously when introduced into human cells. The novel strategy for the isolation of these sequences involved cloning random human DNA fragments into a defective Epstein-Barr virus vector. This vector alone was unable to replicate in human cells, but appeared to provide for the nuclear retention of linked DNA. The human sequences persist in a long-term replication assay (greater than 2 months) in the presence of the viral nuclear retention sequences. Using a short-term (4-day) assay, we showed that the human sequences are able to replicate in the absence of all viral sequences. The plasmids bearing human sequences were shown to replicate based on the persistence of MboI-sensitive plasmid DNA in the long-term assay and the appearance of DpnI-resistant DNA in the short-term assay. The human sequences were shown to be responsible for the replication activity and may represent authentic human origins of replication.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542763      PMCID: PMC362692          DOI: 10.1128/mcb.9.3.1026-1033.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Transformation of mammalian cells with genes from procaryotes and eucaryotes.

Authors:  M Wigler; R Sweet; G K Sim; B Wold; A Pellicer; E Lacy; T Maniatis; S Silverstein; R Axel
Journal:  Cell       Date:  1979-04       Impact factor: 41.582

2.  Transfer of the gene for thymidine kinase to thymidine kinase-deficient human cells by purified herpes simplex viral DNA.

Authors:  S Bacchetti; F L Graham
Journal:  Proc Natl Acad Sci U S A       Date:  1977-04       Impact factor: 11.205

3.  Characteristics of a human cell line transformed by DNA from human adenovirus type 5.

Authors:  F L Graham; J Smiley; W C Russell; R Nairn
Journal:  J Gen Virol       Date:  1977-07       Impact factor: 3.891

4.  Isolation and characterisation of a yeast chromosomal replicator.

Authors:  D T Stinchcomb; K Struhl; R W Davis
Journal:  Nature       Date:  1979-11-01       Impact factor: 49.962

5.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

6.  Partial nucleotide sequence of the 300-nucleotide interspersed repeated human DNA sequences.

Authors:  C M Rubin; C M Houck; P L Deininger; T Friedmann; C W Schmid
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

7.  Cloning and mapping of the replication origin of Escherichia coli.

Authors:  S Yasuda; Y Hirota
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

8.  Ubiquitous, interspersed repeated sequences in mammalian genomes.

Authors:  W R Jelinek; T P Toomey; L Leinwand; C H Duncan; P A Biro; P V Choudary; S M Weissman; C M Rubin; C M Houck; P L Deininger; C W Schmid
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

9.  High-frequency transformation of yeast by plasmids containing the cloned yeast ARG4 gene.

Authors:  C L Hsiao; J Carbon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

10.  Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region.

Authors:  D R Rawlins; G Milman; S D Hayward; G S Hayward
Journal:  Cell       Date:  1985-10       Impact factor: 41.582

View more
  111 in total

1.  Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virus.

Authors:  D Salamon; M Takacs; D Ujvari; J Uhlig; H Wolf; J Minarovits; H H Niller
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

2.  Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Barr virus.

Authors:  M A Lee; M E Diamond; J L Yates
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

3.  Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1.

Authors:  Hong Wu; Priya Kapoor; Lori Frappier
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  The cis-acting family of repeats can inhibit as well as stimulate establishment of an oriP replicon.

Authors:  E R Leight; B Sugden; E R Light
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

5.  Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event.

Authors:  E R Leight; B Sugden
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

6.  Long-term transgene expression in proliferating cells mediated by episomally maintained high-capacity adenovirus vectors.

Authors:  Florian Kreppel; Stefan Kochanek
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

7.  Nuclear scaffold/matrix attached region modules linked to a transcription unit are sufficient for replication and maintenance of a mammalian episome.

Authors:  Andreas C W Jenke; Isa M Stehle; Frank Herrmann; Tobias Eisenberger; Armin Baiker; Jürgen Bode; Frank O Fackelmayer; Hans J Lipps
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-22       Impact factor: 11.205

8.  Sequences adjacent to oriP improve the persistence of Epstein-Barr virus-based episomes in B cells.

Authors:  R E White; R Wade-Martins; M R James
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Replication from oriP of Epstein-Barr virus requires exact spacing of two bound dimers of EBNA1 which bend DNA.

Authors:  J M Bashaw; J L Yates
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

Review 10.  The role of Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.

Authors:  Chi Man Tsang; Sai Wah Tsao
Journal:  Virol Sin       Date:  2015-04-21       Impact factor: 4.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.